Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00993421 · ClinicalTrials.gov registry record · Phase 2
A Weight Loss Study in Overweight Men and Women
A Phase 2 study, sponsored by Eli Lilly and Company.
- Terminated
- Registry status
- Phase 2
- Development phase
- 343
- Enrollment target
NCT00993421 is a Phase 2 study that was terminated before completion, run by Eli Lilly and Company. The registered enrollment target is 343 participants.
The verdict
NCT00993421, a Phase 2 study, was terminated before completion, sponsored by Eli Lilly and Company.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 343 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if LY377604 + sibutramine work better than LY377604 or sibutramine alone in the treatment of obesity.
Interventions
- DRUG Metoprolol
- DRUG Sibutramine
- DRUG LY377604
- DRUG Placebo sibutramine
- DRUG Placebo Metoprolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 343 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00993421
The ClinicalTrials.gov registry entry for NCT00993421 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 343 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Metoprolol is the first listed.
NCT00993421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00993421 about?
NCT00993421 is a clinical study titled "A Weight Loss Study in Overweight Men and Women". The purpose of this study is to determine if LY377604 + sibutramine work better than LY377604 or sibutramine alone in the treatment of obesity.
What is the current status of trial NCT00993421?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 343 participants. The study started on 2009-10. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00993421?
The interventions under investigation include: Metoprolol (DRUG), Sibutramine (DRUG), LY377604 (DRUG), Placebo sibutramine (DRUG), Placebo Metoprolol (DRUG).
Who is sponsoring clinical trial NCT00993421?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.